Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

BIODESIX INC (BDSX)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a straightforward earnings release for Q2 2026 ended June 30, 2026, filed on August 5, 2026. The press release (Exhibit 99.1) announces financial and operating results including revenue of $26.9 million (34% growth), gross margin of 82%, and net loss of $7.3 million, along with full-year 2026 guidance. The Item 2.02 disclosure explicitly states the company "issued a press release announcing the financial and operating results" and incorporates the exhibit by reference, which is the standard format for earnings releases on Form 8-K.

View raw filing on EDGAR →

MANNKIND CORP (MNKD)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

MannKind Corporation issued a press release on August 5, 2026 disclosing Q2 2026 financial results, including total revenues of $109.4M (+43% vs. Q2 2025), along with consolidated statements of operations and balance sheets. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes detailed revenue breakdowns, operating expenses, and net loss of $19.0M for Q2 2026.

View raw filing on EDGAR →

WARRIOR MET COAL, INC. (HCC)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release for Q2 2026 results. The Item 2.02 disclosure states "Warrior Met Coal, Inc. (the 'Company') issued a press release announcing the Company's second quarter 2026 results," with the press release attached as Exhibit 99.1. The exhibit contains detailed financial results including net income of $87.4 million ($1.65 per diluted share), adjusted EBITDA of $156.9 million, revenues of $509.7 million, and operational metrics. This is material to investors as it reports significant earnings growth and operational improvements driven by Blue Creek mine ramp-up.

View raw filing on EDGAR →

Onterris, Inc. (ONT)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Onterris disclosed Q2 2026 financial results (revenue $186.7 million, net income $1.4 million/$0.04 EPS, Adjusted EBITDA $31.9 million) and significantly reduced full-year 2026 guidance due to historically low environmental emergency response revenues, lowering Consolidated Adjusted EBITDA guidance from $125.0–$130.0 million to $117.0–$120.0 million and revenue guidance from $840.0–$900.0 million to $740.0–$790.0 million.

View raw filing on EDGAR →

CoreCivic, Inc. (CXW)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

CoreCivic issued a press release on August 5, 2026 announcing Q2 2026 financial results, including total revenue of $684.9 million (27.3% increase), net income of $37.1 million, diluted EPS of $0.37, and updated full-year 2026 guidance.

View raw filing on EDGAR →

Revolution Medicines, Inc. (RVMDW)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

This is a quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02 (Results of Operations and Financial Condition). The press release discloses financial results including R&D expenses of $394.9M, G&A expenses of $110.2M, and net loss of $644.4M for the quarter, along with cash position of $3.9B and updated full-year 2026 operating expense guidance of $2.1–$2.2B. The filing includes the full press release as Exhibit 99.1, which is the standard format for earnings disclosures.

View raw filing on EDGAR →

IonQ, Inc. (IONQ-WT)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

IonQ issued a press release on August 5, 2026 announcing Q2 2026 financial results, including record GAAP revenues of $80.1 million (287% YoY growth), net loss of $1.87 billion, and raised full-year 2026 guidance to $280–$290 million. This is a standard quarterly earnings release filed under Item 2.02 and furnished as Exhibit 99.1, meeting the definition of earnings_release.

View raw filing on EDGAR →

Red Violet, Inc. (RDVT)

8-K Earnings release confidence 92% filed 2026-08-05 Item 2.02

Red Violet disclosed preliminary financial results for Q2 2026 (three months ended June 30, 2026), including revenue of $26.7 million, net income of $4.96 million, and adjusted EBITDA of $11.22 million. The disclosure includes key operating metrics and a GAAP-to-non-GAAP reconciliation.

View raw filing on EDGAR →

WW INTERNATIONAL, INC. (WW)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

WW International issued a press release and Shareholder Letter on August 5, 2026 announcing financial results for its fiscal quarter ended June 30, 2026. The disclosure includes Q2 2026 revenue of $162.3 million, subscriber metrics, gross margin of 70.3%, net income of $14.1 million, and reaffirmed full-year 2026 guidance. This is a standard quarterly earnings release filed under Item 2.02 with exhibits 99.1 and 99.2 attached.

View raw filing on EDGAR →

Sarepta Therapeutics, Inc. (SRPT)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Sarepta issued a press release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 net product revenues of $328.7 million, GAAP operating income of $13.3 million, and non-GAAP operating income of $86.5 million. The filing explicitly states this is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes detailed financial metrics, revenue breakdowns, and forward guidance narrowing FY 2026 total net product revenue guidance to $1.2-$1.3 billion.

View raw filing on EDGAR →

Alpha Teknova, Inc. (TKNO)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Alpha Teknova issued a press release on August 5, 2026 announcing Q2 2026 financial results, including revenue of $12.2 million (up 18% YoY), gross profit, operating expenses, net loss, and cash flow metrics. The company also raised its 2026 revenue guidance to $45-47 million and improved Free Cash Outflow expectations. This is a standard quarterly earnings disclosure furnished under Item 2.02, with detailed financial statements and forward-looking guidance that would materially affect investor assessment of the company's financial performance and trajectory.

View raw filing on EDGAR →

Great Elm Capital Corp. (GECCO)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Great Elm Capital Corp. issued a press release on August 5, 2026, disclosing its second quarter 2026 financial results, including net investment income of $0.32 per share, NAV of $7.95 per share, and net realized and unrealized gains of $1.9 million. The filing includes complete financial statements (balance sheet and income statement) and management commentary on quarterly performance, which are hallmarks of a quarterly earnings release under Item 2.02.

View raw filing on EDGAR →

AIRGAIN INC (AIRG)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Item 2.02 discloses Airgain's financial results for Q2 2026 (quarter ended June 30, 2026) via press release dated August 5, 2026. The filing reports quarterly revenue of $13.7 million, GAAP net loss of $1.7 million, and adjusted EBITDA of $0.4 million, along with Q3 2026 financial guidance. This is a standard quarterly earnings release materially affecting investor assessment of the company's financial performance and outlook.

View raw filing on EDGAR →

Biomea Fusion, Inc. (BMEA)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Biomea Fusion issued a press release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, including condensed statements of operations and balance sheet data. The disclosure includes net loss of $8.3 million for Q2 2026, R&D and G&A expense details, cash position of $35.2 million, and cash runway projections into Q2 2027. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, material to investors assessing the company's financial condition and burn rate.

View raw filing on EDGAR →

U-Haul Holding Co /NV/ (UHAL-B)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

U-Haul issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing net earnings of $122.9 million (down from $142.3 million in the prior year), earnings per share of $0.63 (down from $0.73), and detailed segment performance metrics. This is a standard quarterly earnings release furnished under Item 2.02, with the full press release attached as Exhibit 99.1.

View raw filing on EDGAR →

BARRETT BUSINESS SERVICES INC (BBSI)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

BBSI reported Q2 2026 financial results with revenues of $319.3 million (up 4%), gross billings of $2.29 billion (up 3%), and net income of $12.9 million or $0.52 per diluted share, along with forward-looking guidance for 2026 gross billings and WSE growth.

View raw filing on EDGAR →

Sight Sciences, Inc. (SGHT)

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

Sight Sciences issued a press release on August 5, 2026 announcing Q2 2026 financial results with revenue of $23.4 million (20% YoY growth) and raised full-year 2026 revenue guidance to $88–$92 million while reducing adjusted operating expense guidance to $92–$94 million.

View raw filing on EDGAR →

Tenaya Therapeutics, Inc. (TNYA)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Tenaya Therapeutics issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, including condensed statements of operations and balance sheet data. The filing discloses Q2 2026 net loss of $43.4 million (versus $23.3 million in Q2 2025), R&D and G&A expenses, and cash position of $78.1 million. This is a standard quarterly earnings release with financial statements and operational updates, fitting the earnings_release category under Item 2.02.

View raw filing on EDGAR →

Enliven Therapeutics, Inc. (ELVN)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

This is a clear earnings release disclosing Enliven's Q2 2026 financial results, including R&D expenses ($29.0M), G&A expenses ($8.2M), net loss ($32.5M), and cash position ($895.2M). The press release is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings announcements. The disclosure includes both financial statements and operational highlights regarding the ELVN-001 clinical program.

View raw filing on EDGAR →

Aeva Technologies, Inc. (AEVA)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Aeva Technologies disclosed Q2 2026 quarterly financial results, reporting revenue of $6.1 million, GAAP operating loss of $34.6 million, and GAAP net loss per share of $1.23, along with balance sheet and cash flow data.

View raw filing on EDGAR →

Paycom Software, Inc. (PAYC)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Paycom issued a press release on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 total revenues of $531.2 million (up 9.8% YoY), GAAP net income of $107.4 million ($2.34 per diluted share), and raising full-year 2026 guidance. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings releases.

View raw filing on EDGAR →

STANDARD BIOTOOLS INC. (LAB)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Standard BioTools issued a press release on August 5, 2026 disclosing financial results for the three and six months ended June 30, 2026, including revenue of $20.1 million for Q2 2026, gross margins of 52.4%, operating loss of $25.4 million, and adjusted EBITDA loss of $2.5 million.

View raw filing on EDGAR →

MYOMO, INC. (MYO)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces financial results including revenue of $11.7 million (up 21% YoY), gross margin expansion to 72.1%, and improved operating losses. The company also raised full-year revenue guidance to $45-47 million. The press release is furnished as Exhibit 99.1 and includes detailed financial statements and forward-looking guidance, which are hallmarks of a material earnings announcement.

View raw filing on EDGAR →

VERRA MOBILITY Corp (VRRM)

8-K Earnings release confidence 94% filed 2026-08-05 Item 2.02

Verra Mobility disclosed Q2 2026 financial results on August 5, 2026, reporting total revenue of $263.6 million and a net loss of $(48.2) million, along with revised full-year 2026 guidance and a conference call announcement. The earnings release, furnished as Exhibit 99.1, includes comprehensive segment performance and material business developments.

View raw filing on EDGAR →

Block, Inc. (BSQKZ)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Block, Inc. issued a Shareholder Letter on August 5, 2026 announcing financial results for Q2 2026 ended June 30, 2026. The letter discloses key financial metrics including gross profit of $3.17B (+25% YoY), operating income of $447M, and diluted EPS of $0.15, along with a raised full-year guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the company's financial performance and outlook.

View raw filing on EDGAR →

Dave Inc./DE (DAVEW)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Dave Inc. issued a press release on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026 (Q2 2026). The disclosure includes quarterly revenue of $170.8 million (30% Y/Y growth), net income of $6.7 million, adjusted EBITDA of $75.5 million (48% Y/Y growth), and updated full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted diluted EPS. This is a standard quarterly earnings release with detailed financial statements and operating metrics, filed under Item 2.02 as required for earnings disclosures.

View raw filing on EDGAR →

Pursuit Attractions & Hospitality, Inc. (PRSU)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

The filing discloses Pursuit's financial results for the second quarter ended June 30, 2026, including record revenue of $133.5 million (14.3% YoY growth), net income of $15.2 million, and Adjusted EBITDA of $32.7 million. The company also updated full-year 2026 guidance upward by $5 million in Adjusted EBITDA to $128–$138 million. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.

View raw filing on EDGAR →

SAIA INC (SAIA)

8-K Earnings release confidence 95% filed 2026-08-05 Item 7.01

The Item 7.01 disclosure furnishes a conference call transcript discussing Saia's second quarter 2026 earnings results. The filing explicitly states it is "the transcript of the conference call to discuss the second quarter earnings of Saia, Inc." The transcript contains detailed financial results including record revenue of $956.5 million (17.1% YoY increase), operating income of $125 million (26% YoY increase), operating ratio of 86.9%, and diluted EPS of $3.51 (31.5% YoY increase). This is a material earnings disclosure that would affect a reasonable investor's assessment of the company's financial performance.

View raw filing on EDGAR →

Apple Hospitality REIT, Inc. (APLE)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Apple Hospitality REIT announced its financial results for the three and six months ended June 30, 2026, via press release furnished as Exhibit 99.1. The disclosure includes comprehensive quarterly and year-to-date financial metrics (net income, operating income, EBITDA, MFFO, RevPAR, occupancy, ADR) and management commentary on operational performance, refinancing activities, and capital allocation. This is a standard earnings release disclosure under Item 2.02.

View raw filing on EDGAR →

Palmer Square Capital BDC Inc. (PSBD)

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

Palmer Square Capital BDC Inc. announced its financial results for the quarter ended June 30, 2026, disclosing net investment income of $12.0 million ($0.39 per share) and net asset value of $13.21 per share, along with portfolio highlights and dividend declarations for the third quarter and a supplemental dividend expected in September.

View raw filing on EDGAR →

HUBSPOT INC (HUBS)

8-K Earnings release confidence 99% filed 2026-08-05 Item 2.02

HubSpot issued a press release on August 5, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, disclosing revenue of $911.7 million (up 20% YoY), GAAP net income of $43.3 million (vs. prior-year loss of $3.3 million), and forward guidance for Q3 and full-year 2026.

View raw filing on EDGAR →

RxSight, Inc. (RXST)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

RxSight issued a press release on August 5, 2026 announcing its financial results for the three months ended June 30, 2026, including total revenue of $33.7 million, product sales of $27.2 million (down 19% year-over-year), and a net loss of $(12.1) million. The filing explicitly states under Item 2.02 that the company "issued a press release announcing its results of operations and financial condition" with the press release attached as Exhibit 99.1. This is a standard quarterly earnings disclosure.

View raw filing on EDGAR →

Innoviva, Inc. (INVA)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Innoviva, Inc. issued a press release regarding its results of operations and financial condition for the quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial results including total revenue of $119.6 million (19% YoY growth), net product sales of $51.8 million (46% growth), and income from operations of $50.9 million, along with condensed consolidated financial statements and management commentary on business performance.

View raw filing on EDGAR →

biote Corp. (BTMD)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

This is a clear earnings release for Q2 2026 ended June 30, 2026, disclosed via press release furnished as Exhibit 99.1 under Item 2.02. The filing reports quarterly financial results including revenue of $44.2 million, net loss of $(7.4) million, and revised full-year 2026 guidance. The disclosure is material as it reflects significant operational challenges from a voluntary product recall and represents a material change in financial performance (net loss vs. prior-year net income).

View raw filing on EDGAR →

Cytek Biosciences, Inc. (CTKB)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Cytek Biosciences issued a press release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $48.1 million (6% increase YoY), gross profit of $28.3 million (19% increase YoY), and updated full-year 2026 revenue guidance to $207–$212 million. This is a standard quarterly earnings release furnished under Item 2.02 and is material to investors assessing the company's financial performance and trajectory.

View raw filing on EDGAR →

BLACK HILLS CORP /SD/ (BKH)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Black Hills Corporation issued a press release on August 5, 2026, announcing financial results for the second quarter of 2026, including GAAP and adjusted EPS, revenue, operating expenses, and reaffirmed 2026 earnings guidance of $4.25 to $4.45 per share. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the earnings release attached as Exhibit 99, which is the standard format for quarterly earnings disclosures.

View raw filing on EDGAR →

Primerica, Inc. (PRI)

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

Primerica reported Q2 2026 financial results with total revenues of $865 million (up 9%), net income of $202 million (up 13%), and diluted EPS of $6.45 (up 19%), along with record investment sales of $4.4 billion (up 23%) and all-time high client asset values of $140 billion (up 16%).

View raw filing on EDGAR →

MKS INC (MKSI)

8-K Earnings release confidence 99% filed 2026-08-05 Item 2.02

MKS Inc. announced its Q2 2026 financial results on August 5, 2026, disclosing revenue of $1,248 million, GAAP net income of $175 million ($2.41 per diluted share), and Adjusted EBITDA of $358 million—all above guidance. The press release, attached as Exhibit 99.1, presents comprehensive quarterly financial statements and forward guidance, which is the hallmark of an earnings release under Item 2.02.

View raw filing on EDGAR →

Excelerate Energy, Inc. (EE)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

The filing discloses Excelerate Energy's financial results for the second quarter ended June 30, 2026, including net income of $50.1 million, adjusted EBITDA of $120.1 million, and diluted EPS of $0.37. The press release is furnished as Exhibit 99.1 and explicitly incorporated into Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes quarterly financial statements, year-over-year comparisons, and revised 2026 guidance, all hallmarks of a quarterly earnings announcement.

View raw filing on EDGAR →

NATUZZI S P A (NTZ)

6-K Earnings release confidence 92% filed 2026-08-05

This is a press release announcing Natuzzi's unaudited financial results for the first quarter ended March 31, 2026, including consolidated revenue (€59.5M vs €78.1M YoY), gross margin (32.9% vs 34.1%), operating loss (€2.0M vs €0.8M), and cash position (€13.8M vs €20.3M). The filing includes full consolidated statements of profit/loss, financial position, and cash flows. While the release also discloses material operational restructuring and delisting risk, the primary disclosure is the quarterly earnings announcement with detailed financial statements.

View raw filing on EDGAR →

Montauk Renewables, Inc. (MNTK)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Montauk Renewables issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026. The disclosure includes key financial metrics (revenues of $54.0 million, net income of $0.2 million, Adjusted EBITDA of $12.3 million) and operational highlights, which is the standard format for a quarterly earnings release under Item 2.02 of Form 8-K.

View raw filing on EDGAR →

LandBridge Co LLC (LB)

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

LandBridge announced Q2 2026 financial results via press release, reporting record revenue of $66.8 million (41% YoY growth), net income of $31.0 million (68% YoY growth), and Adjusted EBITDA of $59.8 million, along with a declared quarterly dividend of $0.12 per share.

View raw filing on EDGAR →

WaterBridge Infrastructure LLC (WBI)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

WaterBridge disclosed its financial results for the quarter ended June 30, 2026, reporting Q2 2026 revenue of $217.8 million (8% sequential growth), net income of $14.6 million, and Adjusted EBITDA of $115.8 million, along with updated full-year 2026 guidance and an investor presentation.

View raw filing on EDGAR →

Amplitude, Inc. (AMPL)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Amplitude issued a press release on August 5, 2026 announcing financial results for Q2 2026 (three and six months ended June 30, 2026), disclosing key metrics including ARR of $410 million (up 22% YoY), revenue of $100.9 million (up 21% YoY), and operating cash flow of $25.6 million. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the archetypal earnings_release event.

View raw filing on EDGAR →

Victory Capital Holdings, Inc. (VCTR)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Victory Capital issued a press release on August 5, 2026, reporting record financial results for Q2 2026, including record revenue, Adjusted EBITDA, and earnings per share. The filing explicitly states this is an earnings press release attached as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard disclosure vehicle for quarterly earnings releases. The press release contains comprehensive financial tables, AUM data, and management commentary on operational performance.

View raw filing on EDGAR →

AGL Private Credit Income Fund

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

Item 2.02 discloses the release of financial results for the second fiscal quarter ended June 30, 2026, with an attached investor report (Exhibit 99.1) containing detailed quarterly results including net investment income of $0.65 per share, NAV per share of $23.28, portfolio composition, and distribution declarations. This is a standard quarterly earnings release for a closed-end fund.

View raw filing on EDGAR →

CrossAmerica Partners LP (CAPL)

8-K Earnings release confidence 97% filed 2026-08-05 Item 2.02

CrossAmerica Partners LP issued a press release on August 5, 2026, announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 net income of $20.8 million, Adjusted EBITDA of $51.8 million, and Distributable Cash Flow of $33.6 million, along with segment performance metrics and balance sheet information.

View raw filing on EDGAR →

Heritage Insurance Holdings, Inc. (HRTG)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Heritage Insurance Holdings issued a press release on August 5, 2026 announcing second quarter 2026 financial results, including record net income of $61.7 million (up 28.5% YoY), EPS of $2.05 per diluted share (up 32.3% YoY), and improved combined ratio of 64.9% (down 8.0 points). The filing explicitly states this is Item 2.02 disclosure of quarterly financial results with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.

View raw filing on EDGAR →

NOVANTA INC (NOVTU)

8-K Earnings release confidence 98% filed 2026-08-05 Item 2.02

Novanta issued a press release on August 5, 2026 announcing financial results for the fiscal quarter ended July 3, 2026. The disclosure includes GAAP revenue of $265.8 million (10.3% increase), net income of $12.5 million, diluted EPS of $0.30, and Adjusted EBITDA of $60.7 million (16.4% increase), along with forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release filed under Item 2.02.

View raw filing on EDGAR →

BioAge Labs, Inc. (BIOA)

8-K Earnings release confidence 95% filed 2026-08-05 Item 2.02

BioAge Labs issued a press release on August 5, 2026 announcing its financial results for the second quarter ended June 30, 2026, including collaboration revenue of $2.4 million, R&D expenses of $24.4 million, and a net loss of $26.1 million ($0.58 per share). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes both financial statements and material business updates regarding clinical trial progress for lead candidate BGE-102.

View raw filing on EDGAR →